The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin

References

1. Chase H. A., Fuller C., Reynolds P. 1981; The role of penicillin-binding proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium. European Journal of Biochemistry 117:301–310
   [Google Scholar]
2. Elliott T. S. J., Greenwood D. 1983; The response of Pseudomononas aeruginosa to azlocillin, ticarcillin and cefsulodin. Journal of Medical Microbiology 16:351–362
   [Google Scholar]
3. Greenwood D., O’Grady F. 1973; Comparison of the response of Escherichia coli and Proteus mirabilis to seven β-lactam antibiotics. Journal of Infectious Diseases 128:211–222
   [Google Scholar]
4. Greenwood D., Eley A. 1982; Comparative antipseudomonal activity of some newer β-actam agents. Antimicrobial Agents and Chemotherapy 21:204–209
   [Google Scholar]
5. Jacobus N. V., Ferreira M. C., Barza M. 1982; In vitro activity of azthreonam, a monobactam antibiotic. Antimicrobial Agents and Chemotherapy 22:832–838
   [Google Scholar]
6. Kayser F. H., Huf E., Homberger F. 1981; The microbiology of cefoperazone. Infection. 9: Suppl 1S6–S12
   [Google Scholar]
7. Livermore D. M., Williams J. D. 1981; In-vitro activity of the monobactam, SQ 26, 776, against gram-negative bacteria and its stability to their β-lactam. Journal of Antimicrobial Chemotherapy 8: Suppl E29–37
   [Google Scholar]
8. Mackintosh I. P., O’Grady F., Greenwood D., Watson B. W., Crichton T. C., Piper R., Ferrer A. 1973; A twelve channel bacterial growth monitoring system. Biomedical Engineering 8:514–515–526
   [Google Scholar]
9. Mollenhauer H. H. 1964; Plastic embedding mixtures for use in electron microscopy. Stain Technology 39:111
   [Google Scholar]
10. Phillips I., Warren C., Shannon K., King A., Flanslo D. 1981; Ceftazidime: in-vitro antibacterial activity and susceptibility to β-actamases compared with that of cefotaxime, moxalactam and other β-actam antibiotics. Journal of Antimicrobial Chemotherapy 8: Suppl B23–31
    [Google Scholar]
11. Richmond M. H. 1980; Resistance of Pseudomonas aeruginosa to antibiotics. In Pseudomonas aeruginosa the organism, diseases it causes and their treatment, edited by Sabath L. D. Hans Huber; Bern: pp 176–190
    [Google Scholar]
12. Spratt B. G., Jobanputra V., Zimmermann W. 1977; Binding of thienamycin and clavulanic acid to the penicillin binding proteins of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 12:406–409
    [Google Scholar]
13. Spratt B. G. 1975; Distinct penicillin-binding proteins involved in the division, elongation and shape of Escherichia coli K-12. Proceedings of the National Academy of Sciences of the United States of America 72:2999–3003
    [Google Scholar]
14. Wise R., Andrews J. M., Patel N. 1981; N-formimidoyl thienamycin, a novel β-lactam: an in-vitro comparison with other β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 7:521–529
    [Google Scholar]